ICD-10 Coding for Basal Cell Carcinoma of Nose(C44.30, C44.311, C44.311B)
Learn about the ICD-10 coding for basal cell carcinoma of the nose, including documentation requirements and common pitfalls to avoid.
Complete code families applicable to Basal Cell Carcinoma of Nose
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C44.311 | Basal cell carcinoma of skin of nose | Use for confirmed cases of basal cell carcinoma located on the nose. |
|
| C44.319 | Basal cell carcinoma of skin of other parts of face | Use when basal cell carcinoma is located on facial areas other than the nose. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutBasal Cell Carcinoma of Nose
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Basal Cell Carcinoma of Nose.
Failing to document lesion laterality.
Impact
Clinical: Impacts treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation
Always specify left or right for asymmetric lesions.
Using unspecified codes like C44.91 for nasal BCC.
Impact
Reimbursement: Claims may be denied or delayed., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data affecting patient records.
Mitigation
Always specify the exact location using C44.311 for nasal BCC.
Use of unspecified codes
Impact
High risk of audit if C44.91 is used without specifying location.
Mitigation
Always use specific codes like C44.311 for nasal BCC.